Jacobs Levy Equity Management’s Puma Biotechnology PBYI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-756,675	Closed	-$2.3M	–	1063
2021 Q4	$2.3M	Buy	756,675 +313,594	+71%	+$1.36M	0.02%	592
2021 Q3	$3.11M	Buy	443,081 +262,137	+145%	+$1.96M	0.02%	531
2021 Q2	$1.66M	Buy	180,944 +6,251	+4%	+$63.3K	0.01%	636
2021 Q1	$1.7M	Buy	174,693 +71,165	+69%	+$795K	0.01%	636
2020 Q4	$1.06M	Sell	103,528 -1,015	-1%	-$10.3K	0.01%	706
2020 Q3	$1.05M	Sell	104,543 -4,146	-4%	-$42.2K	0.01%	652
2020 Q2	$1.13M	Buy	108,689 +25,244	+30%	+$261K	0.01%	643
2020 Q1	$704K	Sell	83,445 -42,730	-34%	-$415K	0.01%	697
2019 Q4	$1.1M	Buy	126,175 +21,355	+20%	+$177K	0.01%	674
2019 Q3	$1.13M	Buy	104,820 +66,460	+173%	+$718K	0.01%	601
2019 Q2	$488K	Sell	38,360 -5,220	-12%	-$120K	0.01%	743
2019 Q1	$1.69M	Buy	43,580 +26,040	+148%	+$795K	0.02%	547
2018 Q4	$357K	Buy	17,540 +12,330	+237%	+$370K	0.01%	785
2018 Q3	$239K	Buy	+5,210	New	+$251K	﹤0.01%	903
2018 Q1	–	Sell	-7,297	Closed	-$721K	–	1041
2017 Q4	$721K	Buy	+7,297	New	+$817K	0.01%	682